查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574986

去识别化健康数据市场，按数据类型、部署模式、应用程式、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

De-identified Health Data Market, By Data Type, By Deployment Mode, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年去识别化健康数据市场规模为 75.4909 亿美元，2024 年至 2032 年复合年增长率为 9.20%。

去识别化健康数据市场-市场动态

对个人化医疗的日益关注推动了去识别化健康数据市场的需求

对个人化医疗的日益关注正在极大地推动去识别化健康数据市场的需求。随着医疗保健提供者越来越多地利用患者资料来客製化治疗，对去识别化的健康资料的需求激增。根据美国卫生与公众服务部的报告，个人化医疗可以带来更好的患者治疗结果并降低医疗成本。此外，「我们所有人研究计画」等措施旨在收集不同人群的资料，以加强个人化治疗方法。 IBM 和Google等主要科技公司正在投资人工智慧和分析工具，以利用去识别化的健康资料进行研究和临床应用，从而促进个人化治疗的进步。这一不断增长的趋势凸显了安全、合规的资料处理在改善医疗服务同时维护病患隐私方面的关键作用。

去识别化健康数据市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 9.20% 左右的复合年增长率成长

根据数据类型细分，预计电子健康记录将在 2023 年显示最大的市场份额

根据部署模式细分，2023年基于云端的部署类型为主导

按地区划分，北美是 2023 年的主要收入来源

去识别化健康数据市场-細項分析：

全球去识别化健康数据市场根据数据类型、部署模式、应用程式和区域进行细分。

根据资料类型，市场分为四类：电子健康记录 (EHR) 由于其全面的患者资讯而处于最高优先级。紧随其后的是索赔数据（提供医疗保健成本见解）、临床数据和基因组数据（提供专业见解）。

根据部署模式，市场分为两类：本地部署和基于云端的。基于云端的部署因其可扩展性和成本效益而受到优先考虑，可以更轻鬆地存取资料。本地解决方案随之而来，儘管需要更多投资，但由于增强了安全性和对敏感健康资讯的控製而受到青睐。

去识别化健康数据市场—地理洞察

在北美，去识别化健康数据市场由美国主导，美国是许多医疗资料公司和高级分析公司的所在地。 2022 年，美国产生了约 220 亿美元的健康资料收入，展示了对数据驱动的医疗保健解决方案的大量投资。在欧洲，由于欧盟的《一般资料保护规范》(GDPR)，该市场正在不断增长，该条例鼓励负责任地使用去识别化资料，从而使德国和英国等国家能够扩展其医疗保健分析能力。同时，亚太地区正成为强而有力的竞争者，印度和中国等国家则专注于数位健康措施。预计到 2025 年，印度医疗保健 IT 产业将成长至 90 亿美元，这表明对去识别化健康资料的需求不断增长。拉丁美洲也认识到健康资料的重要性，巴西实施了健康资料法，促进去识别化资料的使用，以改善公共卫生。这些区域措施正在重塑全球去识别化的健康资料格局。

去识别化健康数据市场-竞争格局：

在去识别化健康数据市场中，在技术进步和强大的医疗保健系统的推动下，北美仍然是领先地区。 2023 年 1 月，健康服务公司 Optum 宣布与一家领先的分析公司建立策略合作伙伴关係，以增强其去识别化健康资料产品，旨在为医疗保健提供者提供先进的见解。同时，在欧洲，西门子医疗与一家欧洲分析公司于 2023 年 3 月进行了重大合作，利用去识别化的患者资料进行研究，从而改善患者的治疗效果。在亚太地区，2022 年底发生了一次值得注意的合併，当时一家着名的健康科技新创公司收购了一家当地资料分析公司，扩大了其在去识别化健康资料管理方面的能力。此外，去识别化健康资料市场的成长得到了有利法规的支持，美国国家健康资讯科技协调员办公室提倡负责任地使用健康资料。这些发展反映了竞争格局的动态本质，强调全球的创新和协作。

最新进展：

2023 年 2 月，Mayo Clinic 平台和 TripleBlind 扩大了合作伙伴关係，以增强去识别化资料的使用和病患隐私。此次合作旨在透过在不损害患者资讯或智慧财产权的情况下实现安全资料分析来改善全球健康结果。

2023 年 4 月，飞利浦和麻省理工学院的 IMES 增强了 eICU 协作研究资料库，使研究人员能够存取来自超过 20 万名重症监护患者的去识别化资料。该计划旨在推动人工智慧在医疗保健领域的发展，并提高临床理解和患者治疗效果。

目录

第 1 章：去识别化健康数据市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按资料类型分類的去识别化健康资料市场片段
    • 按部署模式分類的去识别化健康资料市场片段
    • 按应用分類的去识别化健康数据市场片段
    • 按国家/地区分類的去识别化健康数据市场片段
    • 按地区分類的去识别化健康资料市场片段
  • 竞争洞察

第 3 章：去识别化健康资料主要市场趋势

  • 去识别化的健康数据市场驱动因素
    • 市场驱动因素的影响分析
  • 去识别化的健康数据市场限制
    • 市场限制影响分析
  • 去识别化健康数据市场机会
  • 去识别化健康数据市场未来趋势

第 4 章：去识别化健康资料产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：去识别化健康资料市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：去辨识化健康数据市场格局

  • 2023 年去识别化健康数据市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：去识别化健康资料市场 - 按资料类型

  • 概述
    • 按资料类型分類的细分市场占有率分析
    • 电子健康纪录 (EHR)
    • 索赔数据
    • 临床数据
    • 基因组数据

第 8 章：去识别化健康数据市场 - 按部署模式

  • 概述
    • 按部署模式分類的细分市场占有率分析
    • 本地部署
    • 基于云端的

第 9 章：去识别化健康数据市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 医疗保健研究
    • 病人护理
    • 人口健康管理
    • 药物开发

第 10 章：去识别化健康数据市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美主要製造商的去识别化健康数据
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按数据类型）
    • 北美市场规模和预测（按部署模式）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商的去识别化健康数据
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按数据类型）
    • 欧洲市场规模和预测（按部署模式）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区去识别化健康数据主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按资料类型）
    • 亚太地区市场规模与预测（依部署模式）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商的去识别化健康数据
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按数据类型）
    • 拉丁美洲市场规模与预测（按部署模式）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲的去识别化健康数据主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按资料类型）
    • 中东和非洲市场规模及预测（按部署模式）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 去识别化健康资料产业

  • 竞争仪表板
  • 公司简介
    • Aetion, Inc.
    • Agilent Technologies, Inc.
    • Allscripts Healthcare Solutions, Inc.
    • Cerner Corporation
    • Epic Systems Corporation
    • flatiron health, Inc.
    • GE Healthcare
    • IBM Watson Health
    • McKesson Corporation
    • Medidata Solutions, Inc.
    • Optum, Inc.
    • Oracle Corporation
    • Philips Healthcare
    • QuintilesIMS (IQVIA)
    • SAS Institute Inc.
    • Syapse, Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3995

REPORT HIGHLIGHT

De-identified Health Data Market size was valued at USD 7,549.09 Million in 2023, expanding at a CAGR of 9.20% from 2024 to 2032.

The de-identified health data market involves the collection, analysis, and sale of health data that has been stripped of personally identifiable information, ensuring patient confidentiality. As healthcare organizations increasingly seek insights from big data analytics to improve patient outcomes and operational efficiency, the demand for de-identified data is surging. Factors contributing to this growth include the rising emphasis on personalized medicine, which necessitates large datasets for effective analysis. Furthermore, initiatives promoting interoperability among health systems facilitate data sharing, enhancing the accessibility of de-identified health data. However, challenges such as data security concerns and regulatory compliance issues may hinder market growth. Opportunities exist in the expansion of artificial intelligence and machine learning technologies, which require extensive datasets for training algorithms. For instance, studies indicate that over 80% of healthcare providers plan to invest in analytics solutions by 2025, underscoring the increasing reliance on de-identified health data to drive innovation and improve healthcare delivery.

De-identified Health Data Market- Market Dynamics

Growing Focus on Personalized Medicine Drives Demand in the De-identified Health Data Market

The rising focus on personalized medicine is significantly propelling demand in the De-identified Health Data Market. As healthcare providers increasingly utilize patient data to tailor treatments, the need for de-identified health data has surged. According to a report from the U.S. Department of Health & Human Services, personalized medicine can lead to better patient outcomes and reduced healthcare costs. Additionally, initiatives like the All of Us Research Program aim to gather data from diverse populations to enhance individualized treatment approaches. Major tech firms, including IBM and Google, are investing in AI and analytics tools to leverage de-identified health data for research and clinical applications, facilitating advancements in personalized therapies. This growing trend highlights the critical role of secure and compliant data handling in improving healthcare services while maintaining patient privacy.

De-identified Health Data Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.20% over the forecast period (2024-2032)

Based on Data Type segmentation, Electronic Health Records was predicted to show maximum market share in the year 2023

Based on Deployment Mode segmentation, Cloud-Based was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

De-identified Health Data Market- Segmentation Analysis:

The Global De-identified Health Data Market is segmented on the basis of Data Type, Deployment Mode, Application, and Region.

The market is divided into four categories based on data type: electronic health records (EHR) are the highest priority due to their comprehensive patient information. Following closely are Claims Data, which provides insights into healthcare costs, Clinical Data, and Genomic Data, which offers specialized insights.

The market is divided into two categories based on Deployment Mode: On-Premise and Cloud-Based. Cloud-based deployment is prioritized due to its scalability and cost-effectiveness, allowing easier access to data. On-premise solutions follow, favored for enhanced security and control over sensitive health information, though they require more investment.

De-identified Health Data Market- Geographical Insights

In North America, the De-identified Health Data Market is led by the United States, which is home to numerous healthcare data companies and advanced analytics firms. The U.S. generated approximately $22 billion in health data revenue in 2022, showcasing the significant investment in data-driven healthcare solutions. In Europe, the market is growing due to the European Union's General Data Protection Regulation (GDPR), which encourages the responsible use of de-identified data, allowing countries like Germany and the UK to expand their healthcare analytics capabilities. Meanwhile, the Asia Pacific region is emerging as a strong contender, with countries like India and China focusing on digital health initiatives. India's healthcare IT sector is projected to grow to $9 billion by 2025, indicating a rising demand for de-identified health data. Latin America is also recognizing the importance of health data, with Brazil implementing health data laws that facilitate de-identified data use for public health improvements. These regional initiatives are reshaping the de-identified health data landscape globally.

De-identified Health Data Market- Competitive Landscape:

In the De-identified Health Data Market, North America remains the leading region, driven by technological advancements and robust healthcare systems. In January 2023, Optum, a health services company, announced a strategic partnership with a leading analytics firm to enhance its de-identified health data offerings, aiming to provide advanced insights to healthcare providers. Meanwhile, in Europe, a significant collaboration occurred in March 2023 between Siemens Healthineers and a European analytics company to leverage de-identified patient data for research purposes, enhancing patient outcomes. In the Asia Pacific, a notable merger took place in late 2022 when a prominent health tech startup acquired a local data analytics firm, expanding its capabilities in de-identified health data management. Additionally, the growth of the de-identified health data market is supported by favorable regulations, with the U.S. Office of the National Coordinator for Health Information Technology promoting the responsible use of health data. These developments reflect the competitive landscape's dynamic nature, emphasizing innovation and collaboration across the globe.

Recent Developments:

In February 2023, Mayo Clinic Platform and TripleBlind expanded their partnership to enhance de-identified data usage and patient privacy. This collaboration aims to improve global health outcomes by enabling secure data analysis without compromising patient information or intellectual property rights.

In April 2023, Philips and MIT's IMES enhanced the eICU Collaborative Research Database, providing researchers access to de-identified data from over 200,000 critical care patients. This initiative aims to advance AI in healthcare and improve clinical understanding and patient outcomes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DE-IDENTIFIED HEALTH DATA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Aetion, Inc.
  • Agilent Technologies, Inc.
  • Allscripts Healthcare Solutions, Inc.
  • Cerner Corporation
  • Epic Systems Corporation
  • flatiron health, Inc.
  • GE Healthcare
  • IBM Watson Health
  • McKesson Corporation
  • Medidata Solutions, Inc.
  • Optum, Inc.
  • Oracle Corporation
  • Philips Healthcare
  • QuintilesIMS (IQVIA)
  • SAS Institute Inc.
  • Syapse, Inc.
  • Others

GLOBAL DE-IDENTIFIED HEALTH DATA MARKET, BY DATA TYPE- MARKET ANALYSIS, 2019 - 2032

  • Electronic Health Records (EHR)
  • Claims Data
  • Clinical Data
  • Genomic Data

GLOBAL DE-IDENTIFIED HEALTH DATA MARKET, BY DEPLOYMENT MODE- MARKET ANALYSIS, 2019 - 2032

  • On-Premise
  • Cloud-Based

GLOBAL DE-IDENTIFIED HEALTH DATA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Healthcare Research
  • Patient Care
  • Population Health Management
  • Drug Development

GLOBAL DE-IDENTIFIED HEALTH DATA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. De-identified Health Data Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. De-identified Health Data Market Snippet by Data Type
    • 2.1.2. De-identified Health Data Market Snippet by Deployment Mode
    • 2.1.3. De-identified Health Data Market Snippet by Application
    • 2.1.4. De-identified Health Data Market Snippet by Country
    • 2.1.5. De-identified Health Data Market Snippet by Region
  • 2.2. Competitive Insights

3. De-identified Health Data Key Market Trends

  • 3.1. De-identified Health Data Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. De-identified Health Data Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. De-identified Health Data Market Opportunities
  • 3.4. De-identified Health Data Market Future Trends

4. De-identified Health Data Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. De-identified Health Data Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. De-identified Health Data Market Landscape

  • 6.1. De-identified Health Data Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. De-identified Health Data Market - By Data Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Data Type, 2023 & 2032 (%)
    • 7.1.2. Electronic Health Records (EHR)
    • 7.1.3. Claims Data
    • 7.1.4. Clinical Data
    • 7.1.5. Genomic Data

8. De-identified Health Data Market - By Deployment Mode

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Deployment Mode, 2023 & 2032 (%)
    • 8.1.2. On-Premise
    • 8.1.3. Cloud-Based

9. De-identified Health Data Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Healthcare Research
    • 9.1.3. Patient Care
    • 9.1.4. Population Health Management
    • 9.1.5. Drug Development

10. De-identified Health Data Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. De-identified Health Data Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. De-identified Health Data Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. De-identified Health Data Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. De-identified Health Data Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. De-identified Health Data Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- De-identified Health Data Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Aetion, Inc.
    • 11.2.2. Agilent Technologies, Inc.
    • 11.2.3. Allscripts Healthcare Solutions, Inc.
    • 11.2.4. Cerner Corporation
    • 11.2.5. Epic Systems Corporation
    • 11.2.6. flatiron health, Inc.
    • 11.2.7. GE Healthcare
    • 11.2.8. IBM Watson Health
    • 11.2.9. McKesson Corporation
    • 11.2.10. Medidata Solutions, Inc.
    • 11.2.11. Optum, Inc.
    • 11.2.12. Oracle Corporation
    • 11.2.13. Philips Healthcare
    • 11.2.14. QuintilesIMS (IQVIA)
    • 11.2.15. SAS Institute Inc.
    • 11.2.16. Syapse, Inc.
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us